With a background in healthcare investment banking and years of hands-on experience guiding independent physician groups through mergers, acquisitions, and strategic partnerships, Michael Kroin, CEO and Managing Partner of Physician Growth Partners, knows that selling a medical practice isn’t just a financial decision. In this episode of That’s Derm Good!, Michael joins Janelle to unpack what private equity looks like for dermatologists and aesthetic practice owners today.

DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatment.

Michael Kroin offers clear, no-fluff insight into a landscape that’s often confusing or intimidating. He explains why private equity has become a hot topic in dermatology, what physicians should look for in a partner, and how to avoid common pitfalls. Throughout the conversation, Michael emphasizes a founder-first approach; one that protects the identity of the practice, respects the team, and prioritizes long-term sustainability over short-term gains. He also addresses the role of younger physicians in succession planning, the evolution of aesthetics-focused partnerships, and what the current market tells us about timing and opportunity.

SPONSOR: Sanofi and Regeneron invite you to learn more about DUPIXENT (dupilumab) at www.DupixentHCP.com. No Wonder it’s Possible.

This episode also explores what practice owners can do before they’re ready to sell, whether that means organizing their finances, clarifying long-term goals, or identifying potential gaps in operations or leadership. Michael shares what makes a practice attractive to buyers and how owners can prepare years in advance to keep their options open and their values intact.

This episode is produced by Skip The Boring Stuff, a podcast strategy company for business owners and creatives.